Appeals Court Hands AAM Victory In Maryland Price Gouging Suit

April 13, 2018
A federal appeals court handed the generic drug industry a major win Friday (April 13) by ruling against Maryland's first-in-the-nation generic drug price gouging law. Friday's ruling, which could end up being appealed to the U.S. Supreme Court, could have a major impact on efforts by a dozen other states to pursue drug price-gouging laws. The appeals court raised concerns that a move by other states to enact laws similar to Maryland's would cause a significant burden on interstate commerce...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.